Oncogenic <i>PIK3CA</i> mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.
- DOI
- 10.1136/jitc-2026-014770
- Published
- 2026-07-07
- Container
- J Immunother Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2026-014770,
title = {Oncogenic \<i\>PIK3CA\</i\> mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.},
author = {Su YL and Huang SY and Kuo CW and Xiao LY and Lin CT and Chen YH and Chang LC and Kuo MC and Wu CC and Peng JM and Wu CL and Huang HY and Chien CY.},
year = {2026},
journal = {J Immunother Cancer},
doi = {10.1136/jitc-2026-014770},
url = {https://doi.org/10.1136/jitc-2026-014770}
}RIS
TY - JOUR TI - Oncogenic <i>PIK3CA</i> mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma. AU - Su YL AU - Huang SY AU - Kuo CW AU - Xiao LY AU - Lin CT AU - Chen YH AU - Chang LC AU - Kuo MC AU - Wu CC AU - Peng JM AU - Wu CL AU - Huang HY AU - Chien CY. PY - 2026 JO - J Immunother Cancer DO - 10.1136/jitc-2026-014770 UR - https://doi.org/10.1136/jitc-2026-014770 ER -
APA
YL, S., SY, H., CW, K., LY, X., CT, L., YH, C., LC, C., MC, K., CC, W., JM, P., CL, W., HY, H., & CY., C. (2026). Oncogenic <i>PIK3CA</i> mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.. J Immunother Cancer. https://doi.org/10.1136/jitc-2026-014770
Source records
- europe-pmc · retrieved 2026-09-26T04:14:23.068Z